HIRSHAUT YASHAR 4
4 · HI TECH PHARMACAL CO INC · Filed Oct 16, 2009
Insider Transaction Report
Form 4
HIRSHAUT YASHAR
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2009-10-16−11,250→ 0 totalExercise: $1.92From: 2001-10-26Exp: 2010-10-26→ Common Stock (11,250 underlying) - Exercise/Conversion
Common Stock
2009-10-16$1.92/sh+11,250$21,600→ 34,250 total - Exercise/Conversion
Common Stock
2009-10-14$2.00/sh+6,750$13,500→ 23,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2009-10-14−6,750→ 0 totalExercise: $2.00From: 2000-10-26Exp: 2009-10-26→ Common Stock (6,750 underlying) - Sale
Common Stock
2009-10-16$24.50/sh−11,250$275,625→ 23,000 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.45 to $25.04, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) of this Form 4.
- [F2]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Director's Stock Option Plan.
- [F3]The option became exercisable in four equal annual installments beginning on the first anniversary of the grant date.
- [F4]Dr. Hirshaut is still the holder of options to acquire an aggregate of 93,375 shares of Hi-Tech Common Stock, which options were granted on various dates, with various exercise prices, exercise dates and expiration dates.